PSP Business Brief: Bayer Acquires Merck & Co’s Consumer Care Lines
Bayer has agreed to acquire Merck & Co’s consumer care business for $14.2 billion, according to media reports.
Bayer has agreed to acquire Merck & Co’s consumer care business for $14.2 billion, according to media reports.
If approved, Skinvive by Juvéderm will be the first hyaluronic acid injectable treatment option aiming to reduce neck lines.